ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease.

Min-Ho Nam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.